G. Nowak et al., ADAPTIVE-CHANGES IN THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX AFTER CHRONIC TREATMENT WITH IMIPRAMINE AND 1-AMINOCYCLOPROPANECARBOXYLIC ACID, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1380-1386
Chronic (14 daily injections) treatment of mice with the prototypic tr
icyclic antidepressant imipramine significantly alters ligand binding
to the N-methyl-D-aspartate (NMDA) receptor complex. These effects wer
e compared to a chronic regimen of 1-amino-cyclopropanecarboxylic acid
, a high-affinity partial agonist at strychnine-insensitive glycine re
ceptors which mimics the effects of imipramine in preclinical models p
redictive of antidepressant action. Changes in the NMDA receptor compl
ex after chronic, but not acute treatment with imipramine were manifes
ted as: 1) a reduction in the potency of glycine to inhibit [H-3]5,7-d
ichlorokynurenic acid binding to strychnine-insensitive glycine recept
ors; 2) a decrease in the proportion of high-affinity glycine sites in
hibiting [H-3]CGP 39653 binding to NMDA receptors; and 3) a decrease i
n basal [H-3]MK-801 binding (under nonequilibrium conditions) to sites
within NMDA receptor-coupled cation channels which was reversible by
the addition of glutamate. These effects were observed in cerebral cor
tex, but not in hippocampus, striatum or basal forebrain. Chronic trea
tment with 1-aminocyclopropanecarboxylic acid resulted in changes whic
h parallelled those of imipramine on ligand binding to the NMDA recept
or complex, but the reduction in basal [H-3]MK-801 binding did not ach
ieve statistical significance. These findings indicate that adaptive c
hanges in the NMDA receptor complex could be a feature common to chron
ic treatment with structurally unrelated antidepressants.